Jothydev's Diabetes Research Center

Name

Jothydev's Diabetes Research Center

Legal name

Jothydev's Diabetes Research Centre

Website

https://jothydev.net

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Diabetes Care & Endocrinology Services

NAICS

Offices of Physicians (6211), Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Diabetes (General) (HLAKADAA)

akta.pro secondary industries

Endocrinology & Diabetes Telemedicine Platforms (HLALAGAD), Type 1 Diabetes Care (HLAKADAB), Type 2 Diabetes Care (HLAKADAC), Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing (HLALAIAH)

Keywords

• Diabetes care services
• Endocrinology treatment
• Telemedicine platform
• Diabetes education programs
• Continuous glucose monitoring

Headquarters

HQ city

Trivandrum

HQ country

India

HQ region

Asia

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Consultation Services: Outpatient and inpatient diabetes care consultations across all 5 branches plus telemedicine follow-ups
2. Laboratory Services: Comprehensive diagnostic testing including diabetes-related tests, executive checkups, preventive care packages; quality control backed by Bio-Rad USA and CMC Vellore
3. Pharmacy Sales: Hospital pharmacy offering modern medications, insulin variants including analog insulin, insulin pumps and accessories, CGM sensors, diabetes footwear, and other diabetes supplies with home delivery
4. Educational Programs: RSSDI Advanced Certificate Course in Diabetology (affiliated with Jaipur National University), National Diabetes Educator Program, Jothydev's Diabetes Educator Course, Dreams Diabetes Academy
5. Clinical Trials: Research and clinical trial activities

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Jothydev's Diabetes Research Centre provides multidisciplinary diabetes care — including specialist consultations, Continuous Glucose Monitoring, Insulin Pump Therapy, obesity and Type 1 diabetes clinics, in-patient care, on-site laboratory diagnostics, and an on-site pharmacy — delivered across five Kerala branches and via its proprietary DTMS® telemedicine platform and JDC Care mobile app, complemented by accredited training programs and clinical research.

Product overview

Jothydev's Diabetes Research Centre operates as a single-platform diabetes care ecosystem with DTMS® (Diabetes Tele Management System) as its core telemedicine platform enabling remote consultations and continuous patient monitoring. The center offers specialized clinics (Type 1 Diabetes, Obesity), in-patient care, and comprehensive diagnostic services (Laboratory, Fibroscan, Retina Scan) alongside the JDC Care mobile app for appointment booking and medication ordering. The product portfolio extends to medical services (Continuous Glucose Monitoring since 2004, Insulin Pump Therapy since 2004), academic/training programs (RSSDI Certificate Course, NDEP, JDC Diabetes Educator Course), clinical research trials, and patient education resources (GEMS Newsletter, Knowledge Library). All services are delivered across five Kerala locations (Trivandrum, Kochi, Attingal, Haripad, Kasaragod) with pharmacy and home delivery support.

Differentiator

Problem solved

Functional benefit

Brands

• GEMS Diabetes Newsletter: A diabetes education newsletter providing updates on diabetes management and research.
• Dreams Diabetes Academy

Products and services

• Diabetes Tele Management System (DTMS®) Telemedicine Service Telemedicine-based diabetes care service providing 24/7 remote support, virtual consultations, continuous monitoring, and personalised education for people with diabetes through a multi-disciplinary care team.
• Continuous Glucose Monitoring (CGM) Service Real-time CGM service using a small sensor under the skin to track blood glucose, detect trends, prevent highs and lows, and enhance overall glucose control for diabetes patients.
• Insulin Pump Therapy Service Continuous insulin delivery therapy through a small wearable device that mimics the body's natural insulin release, offering precise dosing, flexibility, and improved blood-sugar control versus multiple daily injections.
• Type 1 Diabetes Clinic Specialist clinic offering dedicated care for Type 1 diabetes patients, providing tailored treatment plans, insulin pump and CGM support, and specialised multidisciplinary attention for adults and children with Type 1 diabetes.
• Obesity Clinic Specialist clinic providing treatment for obesity, integrated with diabetes care services and supported by dietetics and exercise medicine expertise.
• In-Patient Diabetes Care Comprehensive in-patient hospitalisation services for patients requiring admission for diabetes management, complications, or related procedures.
• Laboratory Diagnostics Service Fully automated, quality-controlled diagnostic laboratory offering diabetes-related investigations, TMT, ECG, preventive and executive checkup packages, and other testing, with quality control backed by Bio-Rad USA and CMC Vellore.
• Fibroscan Liver Stiffness Service Non-invasive Fibroscan liver-stiffness screening for early detection of liver complications associated with diabetes, including fatty liver disease.
• Retina Scan / Diabetic Retinopathy Screening Diabetic retinopathy screening using a state-of-the-art Retinometer for thorough eye examination and early detection of retinal complications in diabetes patients.
• Dietetics Department Service Personalised nutrition planning service for Type 1 and Type 2 diabetes patients and obesity management, with meal plans considering medical history, preferences, and health aspirations.
• JDC Pharmacy with Home Delivery On-site hospital pharmacy offering modern medications, analog insulin, insulin pumps and accessories, CGM sensors, diabetes footwear, and other diabetes supplies, with online ordering and home delivery.
• JDC Care Mobile Application Mobile diabetes management application enabling patients to book appointments, order medications from the hospital pharmacy, communicate vitals to healthcare providers, and upload external health documents; provided free of charge to JDC patients.
• RSSDI Advanced Certificate Course in Diabetology Advanced certificate course in diabetology for doctors, accredited by RSSDI (Research Society for the Study of Diabetes in India) and affiliated with Jaipur National University, covering all clinical and organisational aspects of diabetes care.
• National Diabetes Educator Program (NDEP) Program to educate and train clinic support staff as Diabetes Educators using India-specific evidence-based clinical data and guidelines, conducted across 170 pre-selected centres.
• Jothydev's Diabetes Educator Course (JDEC) Online certificate course for healthcare professionals to build proficiency in diabetes management and patient education, aligned with IDF Diabetes Atlas statistics.
• Clinical Trials and Diabetes Research Clinical trials and original research programme in diabetes treatment and management, producing world-class research presentations and publications and supporting evidence-based practice at JDC.

Quantifiable outcome

• Serving patients from 25 countries worldwide
• +2 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core.

• International Diabetes Federation (IDF)coreStrategic or Co-development PartnerIDF accreditation as Center of Excellence for education and diabetes care; sole IDF recognized comprehensive diabetes care center in Kerala; IDF School of Diabetes partnership for education programs
• National Accreditation Board for Hospitals & Healthcare Providers (NABH)coreStrategic or Co-development PartnerNABH accreditation for quality standards in healthcare delivery
• Research Society for the Study of Diabetes in India (RSSDI)coreStrategic or Co-development PartnerRSSDI accreditation for Advanced Certificate Course in Diabetology; course recognized by Jaipur National University
• Jaipur National UniversitycoreStrategic or Co-development PartnerAffiliation for RSSDI Advanced Certificate Course in Diabetology - course certificate awarded by the university

Scale indicators3 records

Recent moves4 records

Expansion highlights5 records

Broad incumbents

• Dexcom: Global leader in continuous glucose monitoring hardware and software. JDC's CGM service (since 2004) and JDC Pharmacy's CGM sensor sales depend on partnerships with incumbents like Dexcom, making it both a supplier relationship and a benchmark for the technology layer of JDC's care delivery.
• Practo: India-headquartered telemedicine and doctor-booking platform offering multi-specialty online consultations, including endocrinology. Broad incumbent competing with JDC's DTMS® and JDC Care app for digital diabetes consultation demand at a national scale.
• Tata 1mg (1mg): India's leading digital health platform spanning ePharmacy, teleconsultations, and diagnostics. Comparable to JDC's pharmacy-with-home-delivery and telemedicine offerings but as part of a broader multi-specialty healthcare marketplace rather than a diabetes specialist.
• Medtronic Diabetes: Global leader in insulin pumps (MiniMed) and integrated CGM-based automated insulin delivery. JDC prescribes and supports Medtronic pumps as part of its Insulin Pump Therapy offering, so Medtronic is both a device supplier and a broad incumbent shaping the diabetes technology ecosystem JDC operates in.

Emerging players

• Sugar.fit: India-based diabetes reversal and management platform combining CGM, AI coaching, endocrinologist consultations, and lifestyle programs. Overlaps JDC's Type 2 diabetes, obesity, and lifestyle-modification offerings with a tech-enabled subscription model targeting younger and metro patients.
• BeatO: India-based digital diabetes management platform offering connected glucometers, CGM, teleconsultations with endocrinologists, and subscription care plans. Competes with JDC's DTMS® telemedicine and JDC Care app in the same patient segment, but with a digital-first, asset-light model.
• Wellthy Therapeutics: India- and Asia-focused digital therapeutics company for diabetes, cardiovascular, and respiratory conditions, partnering with insurers and pharma. Adjacent competitor to JDC's DTMS® educator-driven telehealth model, especially in payer-funded chronic care programs.

Direct peers

• Dr. Mohan's Diabetes Specialities Centre: India's largest chain of standalone diabetes super-specialty centres (Chennai-headquartered, 30+ branches). Closest direct competitor to JDC: same single-specialty model, same physician-led diabetes focus, similar reliance on in-house lab, pharmacy, and complication screening, and overlapping target patient segment.
• Apollo Sugar: Apollo HealthCo's diabetes-focused clinic chain operating across multiple Indian cities. Directly comparable to JDC's multi-branch diabetes model, with similar services (consultation, CGM, diet, education) but backed by Apollo's hospital infrastructure and broader brand.
• Diabetacare: India-headquartered diabetes care provider combining specialist consultations, connected CGM, AI-driven remote monitoring, and home delivery of supplies. Directly comparable to JDC's integrated diabetes + telemedicine + pharmacy model, with greater digital emphasis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/jdctvm
• LinkedInlinkedin.com/company/jothydevs

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jothydev's Diabetes Research Center